EKF Diagnostics (LON:EKF) Shares Up 27.3% - Time to Buy?

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) shares shot up 27.3% on Thursday . The company traded as high as GBX 26.90 ($0.36) and last traded at GBX 25.20 ($0.33). 2,253,335 shares were traded during mid-day trading, an increase of 353% from the average session volume of 497,132 shares. The stock had previously closed at GBX 19.80 ($0.26).

EKF Diagnostics Stock Up 3.2%

The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The business's fifty day simple moving average is GBX 21.33 and its two-hundred day simple moving average is GBX 23.89. The company has a market cap of £114.67 million, a PE ratio of 24.01 and a beta of 0.57.

EKF Diagnostics (LON:EKF - Get Free Report) last released its quarterly earnings data on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. On average, analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.

Insider Transactions at EKF Diagnostics

In other EKF Diagnostics news, insider Gavin T. Jones acquired 50,000 shares of the company's stock in a transaction that occurred on Tuesday, March 25th. The stock was bought at an average price of GBX 22 ($0.29) per share, with a total value of £11,000 ($14,612.11). Corporate insiders own 5.24% of the company's stock.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.